Course Hero Logo

ZIDOVUDINE_UY TINA_ob.docx - A Drug Study on ZIDOVUDINE _...

Course Hero uses AI to attempt to automatically extract content from documents to surface to you and others so you can study better, e.g., in search results, to enrich docs, and more. This preview shows page 1 - 3 out of 6 pages.

A Drug Study onZIDOVUDINE_____________________________________________________In Partial Fulfillment of theRequirements in NCM 209 RLE_____________________________________________________OB/GYNE ROTATIONSubmitted to:RODELIZA FAITH B. GUILLERMO, RN, MNClinical InstructorSubmitted by:ARIANNE JOSEPHINE L. UY TINABSN 2C - GROUP 1March 05, 2022
Generic NameZidovudineBrand NameRetrovir, Novo-AZTClassificationTherapeutic: AntiretroviralPharmacologic:Nucleoside reverse transcriptaseinhibitor (NRTI)Pregnancy category:CSuggested dosePrevention of Maternal-Fetal HIV-1 TransmissionPO for Pregnant patient with AOG >14 weeks: 100mg 5 times daily until labor begins.IV for Pregnant patients during labor anddelivery: 2 mg/kg over 1 hour, then continuous IVinfusion of 1 mg/kg until umbilical cord is clamped.Begin IV 3 hours before scheduled cesareandelivery.PO for Neonates within 12 hours after birth:2mg/kg every 6 hours, to continue through 6 weeksof age.IV for Neonates within 12 hours after birth:1.5mg/kg over 30 minutes, every 6 hours, tocontinue through 6 weeks of age.Mode of ActionZidovudine is a nucleoside reverse transciptaseinhibitor (NRTI) that works by interfering with anenzyme called reverse transcriptase (RT), which

Upload your study docs or become a

Course Hero member to access this document

Upload your study docs or become a

Course Hero member to access this document

End of preview. Want to read all 6 pages?

Upload your study docs or become a

Course Hero member to access this document

Term
Winter
Professor
N/A
Tags
zidovudine

Newly uploaded documents

Show More

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture